Defecetive Drugs: adrugrecall.com
NEWS
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Subscribe To Our Syndicated NewsSEC requests Celebrex, Bextra data
August 9, 2005
The Securities and Exchange Commission requested information and documents on Pfizer Inc.'s Celebrex and Bextra painkillers in the second quarter, according to a company filing.
Pfizer is the world's biggest drugmaker but has been facing public scrutiny over its two Cox-2 inhibitor drugs ever since Merck & Co. announced it was withdrawing its similar drug Vioxx from the market last September. Vioxx was linked to double the risk of heart attacks and stroke when used for 18 months or longer.
Bextra was also pulled from the market because of safety risks in April. The U.S. Food and Drug Administration ordered Pfizer and 19 other popular prescription competitors to provide stronger drug warnings about possible cardiovascular risks in pain relievers.
Similar requests for information and documents have been made from the Department of Justice and a group of state attorneys generals regarding Celebrex and Bextra. The latest SEC request did not come as a surprise to analysts.For more information on Celebrex and Bextra, please contact us to confer with a Celebrex Lawyer or Bextra Lawyer and learn your legal rights and options.
More Recent Defective Drug News
